...
首页> 外文期刊>Journal of Controlled Release: Official Journal of the Controlled Release Society >Delivery strategies for treatment of age-related ocular diseases: From a biological understanding to biomaterial solutions
【24h】

Delivery strategies for treatment of age-related ocular diseases: From a biological understanding to biomaterial solutions

机译:老年性眼病的治疗策略:从生物学的认识到生物材料的解决方案

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Age-related ocular diseases, such as age-relatedmacular degeneration (AMD), diabetic retinopathy, and glaucoma, result in life-long functional deficits and enormous global health care costs. As theworldwide population ages, vision loss has become a major concern for both economic and human health reasons. Due to recent research into biomaterials and nanotechnology major advances have been gained in the field of ocular delivery. This review provides a summary and discussion of the most recent strategies employed for the delivery of both drugs and cells to the eye to treat a variety of age-related diseases. It emphasizes the current challenges and limitations to ocular delivery and how the use of innovative materials can overcome these issues and ultimately provide treatment for age-related degeneration and regeneration of lost tissues. This review also provides critical considerations and an outlook for future studies in the field of ophthalmic delivery. (C) 2015 Elsevier B.V. All rights reserved.
机译:与年龄有关的眼病,例如与年龄有关的黄斑变性(AMD),糖尿病性视网膜病和青光眼,会导致终生的功能缺陷和巨大的全球医疗费用。随着全世界人口的老龄化,出于经济和人类健康原因,视力丧失已成为主要关注的问题。由于对生物材料和纳米技术的最新研究,在眼部递送领域已取得重大进展。这篇综述总结和讨论了将药物和细胞输送到眼睛以治疗各种与年龄有关的疾病的最新策略。它强调了眼部输送的当前挑战和局限性,以及使用创新材料如何克服这些问题并最终为与年龄有关的变性和丢失组织的再生提供治疗。这篇综述还提供了重要的考虑因素,并展望了眼科给药领域的未来研究。 (C)2015 Elsevier B.V.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号